Journal
MATERIALS TODAY SUSTAINABILITY
Volume 13, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.mtsust.2021.100078
Keywords
Gold nanoparticles; Plasmonic photothermal therapy; Localized surface plasmon resonance; Cancer treatment
Funding
- SOAR Fellowship from the University of Sydney
- Nantong Science & Technology Plan [JC2018083]
- University of Sydney International Scholarship Strategic (USydIS-Strategic)
Ask authors/readers for more resources
Gold nanoparticles based Plasmonic Photothermal Therapy (PPTT) shows potential in cancer treatment by inducing local hyperthermia in cancer cells or tissues. Among three commonly studied gold nanostructures, gold nanostars (AuNSTs) demonstrate the highest photo-thermal conversion efficiency, making them the most promising agent for PTT therapy.
Gold Nanoparticles based Plasmonic Photothermal Therapy (PPTT) has recently been extensively studied in cancer treatment, based on the local hyperthermia induced by their plasmonic photothermal effect on cancer cells or tissues. Although AuNPs with various morphologies have shown photothermal conversion capabilities, their performance in photothermal therapy is still in debate. To reveal the AuNPs with the most promising PPTT performance, three commonly established gold nanostructures: gold nanospheres (AuNSs), gold nanorods (AuNRs), gold nanostars (AuNSTs), were synthesized in this study with identical mPEG-SH surface modification. The corresponding PTT performance and antitumor effect were evaluated and compared. It was found that all AuNPs can convert 808 nm Near-Infrared (NIR) laser light energy into heat through the Localized Surface Plasmon Resonance effect, and AuNSTs showed the highest photo-thermal conversion efficiency. In vitro cell experiments demonstrated that all PEGylated AuNPs had low cytotoxicity and AuNSTs were the most capable ones in inducing local hyperthermia under an identical condition of 10 min 300 mW/cm(2) NIR light irradiation. Therefore, with the same surface modification, AuNSTs should be the most promising agent for PTT therapy among their counterparts. (C) 2021 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available